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the manner in which the three groups of patients were se-
lected and the inherently subjective process of choosing
the ‘‘most modifiable’’ complications in these groups.
Finally, as shown in Table 2, there was a change in the dis-
tribution of these patient types over the two time periods. For
example, we observed an increase in the incidence of elderly
patients (8% to 9%), an increase in the number of obese pa-
tients (3% to 4%) and an increase in patients with compro-
mised pulmonary function (12% to 16%) during the second
half of this study. These trends are not surprising and have
been observed by others.13 These limitations must be con-
sidered when interpreting these data.
In summary, the construction of a prospective database
and subsequent collection of accurate data allow for the re-
view of surgical outcomes. The information can identify
specific groups of high-risk patients who are more likely
to incur specific types of complications. Outcome data pro-
vide the impetus to make changes to postoperative care algo-
rithms, and these changes may improve surgical results.
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Dr K. Robert Shen (Rochester, Minn). Congratulations on an
excellent presentation and study. Your group has been one of the
strongest proponents of the idea that by critically analyzing andThe Journal of Thoracic and Cchallenging many of the commonly used but unstudied aspects of
the manner in which pulmonary resections are performed, impor-
tant improvements and advances that benefit our patients can be
achieved. We are all indebted to you for recent prospective random-
ized reports demonstrating that the use of preemptive analgesia of
the skin before thoracotomy, the use of intracostal rather than para-
costal sutures, and the use of an intercostal muscle flap all can re-
duce the pain of thoracotomy. Your group has also reported that
the use of early water seal instead of suction on chest tubes and
use of a classification system quantifying the magnitude of air leaks
allow early dismissal from the hospital by allowing aggressive use
of Heimlich valves as well as early chest tube removal in patients
with prolonged air leaks or high outputs.
In this study, you have demonstrated, using a multivariate regres-
sion analysis, that several patient characteristics can be identified
that can predict failure of your postoperative fast-tracking protocol
owing to increased morbidity. The fast-tracking algorithm has been
modified by substituting pain pumps for epidurals in elderly patients
to decrease the incidence of postoperative confusion and overseda-
tion and by the application of increased aspiration precautions and
more frequent respiratory treatments and aggressive physical ther-
apy in obese patients and those with marginal pulmonary function.
This has resulted in a statistically significant reduction in the hospi-
tal length of stay, in morbidity, and in overall mortality.
Given all of the previously mentioned studies from your group
during the study time period, it would seem to me that the conduct
of the operation as well as many aspects of the postoperative care
were very different for the patients in the contemporary study
time period compared with those in the historical control. In the
draft of the manuscript I received, you report a reduction in the
mean operative time from 83 minutes to 72 minutes, a reduction
of 14%, which approached statistical significance, suggesting
a learning curve effect. How can you be confident that the observed
improvements in outcome were due to these specific modifications
in the protocol and not simply the result of other modifications in
your operative technique or postoperative care protocol that were
implemented during this study period?
DrCerfolio. Thank you, Dr Shen, for your very kind comments.
Your points are well taken. The short answer is, you are right. I to-
tally agree. This is a fun study to shoot holes in. My 13-year-old,
Alec, and my 10-year-old, Matthew, shot arrows at this one, and
they and you should, because it is retrospective and flawed by all
of the things that you mentioned. On the other hand, we have tried
our best to be very specific about our changes, and many of our
studies and changes probably did not affect this study’s findings
too much. I do not operate over Christmas and New Year’s every
year. I sit down with my team and say, ‘‘What did we do well
this year and what did we do poorly?’’ We try to implement
changes for the many things we did not do well starting in January.
So there are other changes that occurred. You have mentioned
some, and there are others that we know about and then probably
some others that we are not aware of. We all know that any time
you have a series, the second half of the patients you operate on
do better than the first half because you are more experienced,
your patient selection may get better, and your team is more expe-
rienced. Therefore, all of your points are correct. However, we tried
and really could not identify anything more specific for the changes
in our results than the ones we presented today. Finally, theardiovascular Surgery c Volume 137, Number 5 1177
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have residents and fellows whom I am still teaching.
Dr Shen. One of the proposed benefits of fast-tracking protocols
for surgical patients is that by standardizing postoperative care and
adopting evidence-driven, best-demonstrated practices, there will
be less variability in the care delivered. This will result in decreased
hospital length of stay and a reduction in overall costs to the health
care system, as well as a decrease in overall resource use. In the cur-
rent environment of rising health care costs, this is an important
goal. However, for real cost savings to be realized and resource
use to be reduced, decreased initial hospital length of stay that re-
sults from adoption of fast-tracking protocols cannot be offset by
higher rates of hospital readmission. My question is, do you
know how the hospital readmission rates compare before and after
these specific protocol modifications were implemented?
Dr Cerfolio. That is a great question. Although we do not have
that specific number in the manuscript, it would be nice to know. I
know now that our readmission rate is higher, but it is higher now
because I actually have hired somebody to help us more honestly
and specifically track that information. Now we do a better job get-
ting that information and we have better follow-up. In addition, my
90-day mortality has gone up and my hospital readmissions have
gone up now that I am actually more actively trying to find out
what happens. It is ironic how many patients are not doing as
well as they were when we saw them in the clinic at postoperative
day 21 and we thought and reported that all was well.
Dr Shen. My final question is this: The modifications you have
made to your fast-tracking protocol seem applicable to a wider
group of patients than just those who are elderly, obese, and those
with compromised pulmonary function. In your multivariate anal-
ysis, pneumonia was also the most common morbidity prolonging
hospital stay in all of the other groups identified at higher risk
for failure of a fast-tracking protocol, specifically those with male
gender, white race, those undergoing induction therapy before
resection, those with malignant etiologies, and adenocarcinoma
histology. Have you considered applying the protocol modifica-
tions described here today to all of these subgroups in your clinical
practice, and, if not, why not?
Dr Cerfolio. To answer your last question, what I always tell the
residents and the fellows is that when dealing with hospital admin-
istrators, you try to win small battles one at a time and then maybe
you will eventually win the war. I thought it would be unrealistic to
ask to get enough respiratory therapists to treat all of our patients.
We said: Here are the high-risk patients, the ones we are having
morbidity with still. Here are our data of the patients who did
poorly. Let’s get enough ancillary assistance to take care of 20%
or 30%, which are our high-risk patients, and then we will show
you data that shows the impact we have accomplished with that
care. Then maybe with that information we will be able to get
more help for the other patients as well. I did not know whether
they would buy it up front for everyone, I agree that I want it for
everybody.
Dr W. Roy Smythe (Temple, Tex). Will they buy a 1.8-day de-
crease in length of stay times 3000 patients, which is several million
dollars of diagnosis-related group savings for the hospital?
Dr Cerfolio. I hope so, because we have shown them this ab-
stract, and we look forward to its potential publication to do just
that. We will see.1178 The Journal of Thoracic and Cardiovascular SuDr Scott J. Swanson (New York, NY). Impressive numbers
there, Dr Cerfolio. I have two quick questions. First, in the older
than 70 group, do you know how many got lobeectomies, wedge
resections, and segmentectomies, and did that change over the
course of the 2 years?
Dr Cerfolio. I don not have that number, but I do not think it
changed. I still favor lobectomies even for elderly patients. You
and I know that whether they are 100 years old or whether they
are 60, it is their performance and pulmonary function, not their
chronologic age, that matter. I would be surprised if there was a dif-
ference. I still favor lobectomy in the vast majority of patients.
Dr Swanson. Is that true for those with low pulmonary function
as well?
Dr Cerfolio. No. Of course, if the patient had low pulmonary
function, we would not favor lobectomy. I would do a segmentec-
tomy for a lesion that is less than 2 cm, but they all get the complete
thoracic lymphadenectomy—all the N2 and N nodes come out.
Dr Swanson. Just to follow up on that last point, how do you
gauge respiratory and physical therapists? Is it a certain number?
Is it per patient? How do you make that argument? How many
do you have?
Dr Cerfolio. That is a great question, and it varies on the day of
the week, and, of course, it is different on the weekends. I used to
try to only do 4 or 5 cases on Friday, and now I do 8 or 9 cases on
Friday like my other operative days, on Monday, Tuesday and
Wednesdays. Now only half of those are thoracotomies. I do not
do more than 3 or 4 thoracotomies a day. You will see from my vol-
ume that half my cases are small, mediastinoscopies, video-assisted
thoracic surgery, and so on, and half are thoracotomies. So it really
varies. We try to do less risky procedures on Friday and maybe
even fewer operations on Friday and try to gauge the amount of an-
cillary care per patient, per bed, per floor. That is how they tried to
figure it out, but it seems social issues even dictate who we do and
when, and then we do the best we can. We prefer 4 nurses per pa-
tient, and 1 respiratory therapist for 10 patients if possible.
Dr Mark J. Krasna (Towson, Md). I have a specific question
regarding your patients who received chemotherapy and radiation
therapy. Obviously during this time frame, you also increased the
number of patients you were operating on after high-dose chemo-
radiotherapy.
Dr Cerfolio. Right.
Dr Krasna. Can you comment on the impact over the time
frame in length of stay? Also, I know you are not trying to fast-track
those patients, but, as Dr Shen mentioned, you are applying what
you have learned now from those patients to those having postche-
moradiotherapy lobectomy, for instance. How has that affected
your length of stay and other outcomes?
Dr Cerfolio. That is a good question. One of the things that Dr
Bryant mentioned is that the acuity has gone up. We have had more
elderly patients in the second half, more patients with poor pulmo-
nary function, and a lot more patients who got preoperative radia-
tion and chemotherapy. We used to use 60 Gy, then we went to 66
Gy, and now we are up to 72 Gy almost routinely. I have not really
noticed a difference in the operative field because we are in there
within a few months. I think fast-tracking is all about communica-
tion. If you tell the family in the clinic before surgery that the plan is
this each day and that most go home on postoperative day 3 or 4 and
you do them on Monday, and you tell them on Monday rounds,rgery c May 2009
Bryant and Cerfolio General Thoracic Surgery
G
T
S‘‘Things went well in the operating room. You’ll probably go home
Wednesday or Thursday,’’ and you tell them on Tuesday and you
tell them on Wednesday, they go home Thursday because they are
prepared for it mentally. It is all about communication and prepar-
ing things at home ahead of time. We have not seen an increase in
length of stay. However, I think there is increased recidivism. We
have seen more of those patients come back with just fatigue or
weakness. They are billed as pneumonia by their home physicians
when they get admitted, but when they get transferred back to us
they seem to me many times to have a typical postthoracotomy ra-
diograph; they are just weak. I think we have had a higher recidi-
vism and readmission rate for those reasons, and maybe that is
a failure of fast-track if they are more likely to come back.
Dr Michael T. Jaklitsch (Boston, Mass). The postoperative
confusion, the delirium, the somnolence is really a continuous vari-
able. How do you define that? Second, I am always interested in
anybody who has ideas about how to avoid this in the over-80
group. Do you adjust antidepressants or antianxiolytics? Do you
adjust alcohol consumption preopoperatively? How do you man-
age the pain postoperatively?
Dr Cerfolio. Great questions. Your first question is about our
definitions. We have very strict definitions in the manuscript for
pneumonia and confusion, and these are all widely accepted. I
can talk to you later about how we did it, but it is in the manuscript,
and we were consistent throughout. That is one good thing about the
study. One of the more difficult things about the study is that we did
other things to decrease confusion. That sort of muddies our conclu-
sions, as Dr Shen mentioned and I agree. I am not a fan of the ICU.
When my patients go to the ICU, I lose control at the University of
Alabama at Birmingham. They are being taken care of by anotherThe Journal of Thoracic and Cteam and I cannot even write orders there. Often there is a junior res-
ident who has not rotated on our service. Those residents and the
ICU attendings are great, but I do not think they have the experi-
ence, nor do they have the reportability to me in the morning. We
send almost nobody to the ICU, and that has helped decrease con-
fusion. All 80-year-old patients having pneumonectomy go to the
surgical ward. All patients having esophagectomy go to the surgical
ward. They are monitored on the surgical ward, and it is a good sur-
gical ward, but we avoid the ICU. This allows the family members
to be around them all the time, and that really reduces confusion. An
82-year-old patient is not going to recognize me, but he or she is go-
ing to recognize a daughter. So we invite the family to be part of the
care and stay in the room. That has helped us. We give them almost
no drugs—almost nothing but acetaminophen (Tylenol) for pain.
Finally, your third question was about pain control. We insert
these intraoperative subpleural pain pumps. We use those routinely
when patients do not get an epidural. If they cannot get the epidural
in place before the operation in 15 to 20 minutes, they are going to
get a pain pump because we do not want to delay things. But none
of the elderly patients get epidurals at all. When you drill holes in
the bottom ribs, you do an intercostal nerve block; you do preemp-
tive analgesia before you put the retractors in. Elderly patients have
so much less pain than younger patients that all we give them, and
this really works, is Tylenol, sometimes Extra-Strength Tylenol. If
you can limit the medicines you give the elderly and give them al-
most nothing, they will not be confused. Their pain is not like that
in a younger patient. We have even avoided ketorolac trometh-
amine (Toradol) in those patients because their creatinine levels
come up high and we run them dry. Just Tylenol works well in
most all of them.ardiovascular Surgery c Volume 137, Number 5 1179
